Trial intelligence / Profile preview

Eszopiclone and Lexapro in Depression with Insomnia

NCT00826111Phase 4Completed

Sponsor
St. Elizabeth's Medical Center
Start
Aug 2007
Primary completion
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of eszopiclone in major depressive disorder (MDD), anxiety disorder, Insomnia, sponsored by St. Elizabeth's Medical Center. Started Aug 2007; status: completed.

02

Drugs

eszopiclone
03

Conditions

major depressive disorder (MDD)anxiety disorderInsomnia

Beyond the preview

Go deeper on NCT00826111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00826111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call